Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 62,221 PCSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 62,221 | n/a |
| Jun 30, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Exercise/Conversion | 203 | n/a |
| Apr 2, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 789 | $2.0K |
| Mar 16, 2026 | Akari Therapeutics Plc (AKTX) | Purchase | 2,473 | n/a |
| Oct 3, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 100,000 | n/a |
| Jul 28, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 175,299 | n/a |
| Mar 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 175,000 | n/a |
| Mar 10, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 4,464 | $5.0K |
| Jan 10, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 8,000,000 | $4.8K |
| Dec 26, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 2,000,000 | $1.0K |